Synoptics Health

Synoptics Health is a medical technology company specializing in advanced imaging systems for the detection of residual protein on surgical instruments. The company's flagship product, the ProReveal system, utilizes sensitive fluorescence-based technology to provide a quantitative assessment of instrument cleanliness, far exceeding the capabilities of traditional visual inspections. By identifying ultra-low levels of protein contamination, the system helps hospitals and sterile service departments verify the efficacy of their decontamination processes. This technology is critical for reducing the risk of surgical site infections and the transmission of protein-based pathogens such as prions. Synoptics Health operates as a division of Synoptics Ltd, which is part of the UK-based SDI Group.